Project Details
Description
A Randomized Phase 2 study of iberdomide maintenance therapy following Idecaptagene Vicleucel in multiple myeloma patients
| Status | Active |
|---|---|
| Effective start/end date | 1/2/25 → 1/1/28 |
Funding
- ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.